✦ LIBER ✦

Octreotide as first-line treatment for women with metastatic breast cancer

✍ Scribed by James N. Ingle; Carl G. Kardinal; Vera J. Suman; James E. Krook; Alan K. Hatfield

Publisher: Springer US
Year: 1996
Tongue: English
Weight: 164 KB
Volume: 14
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00210797

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Palliative chemo-radiotherapy with ifosf

Palliative chemo-radiotherapy with ifosfamide and epirubicin as first-line treatment for high-risk metastatic breast cancer

✍ O. F. Lange; W. Scheef; K. D. Haase; M. Heckmann; R. Leyendecker; G. Urban; G. Z 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 460 KB

The use of mitoxantrone plus cyclophosph

The use of mitoxantrone plus cyclophosphamide as first-line treatment of metastatic breast cancer

✍ Werner R. Bezwoda; Charles Hesdorffer 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 2 views

Vinorelbine and docetaxel as first-line

Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer

✍ M. Vassilomanolakis; G. Koumakis; S. Drufakou; G. Aperis; M. Demiri; V. Barbouni 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 193 KB

Liposomal pegylated doxorubicin plus vin

Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65

✍ Raffaele Addeo; Vincenzo Faiola; Rosario Guarrasi; Liliana Montella; Bruno Vince 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 176 KB

Mitoxantrone as a first-line treatment o

Mitoxantrone as a first-line treatment of advanced breast cancer

✍ Karl Landys; Stig Borgstrom; Torsten Andersson; Henry Noppa 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 354 KB

Forty-two Women with measurable or evaluable advanced breast cancer who had received neither prior chemotherapy for advanced disease nor any anthracycline-containing regimen as adjuvant were entered in a phase II study of mitoxantrone (Novantrone| dihydroxyanthracenedione). Patients were aged from 3

A phase II study of paclitaxel plus carb

A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma

✍ Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 3 views

## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi